Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Spears

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Targets|May 22, 2009
The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancerMelanie Spears, John Bartlett
Molecular Diagnosis & Therapy|November 21, 2009
Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selectionMelanie Spears, John M S Bartlett
Journal of the National Cancer Institute|January 10, 2014
Validated or not validated? That is the questionJohn M S Bartlett, Kathleen I Pritchard, Melanie Spears
Genome Medicine|June 30, 2017
ISOWN: accurate somatic mutation identification in the absence of normal tissue controlsIrina Kalatskaya, Quang M Trinh, Melanie Spears, et al.
Journal for Immunotherapy of Cancer|June 4, 2026
Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to "revive" immunotherapy as a treatment strategy?Isabella Kojundzic, Cody Zatzman, Julia Belone Lopes, et al.
Journal of Ovarian Research|April 6, 2018
Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancerTaryne Chong, Amila Sarac, Cindy Q Yao, et al.
Breast Cancer Research : BCR|May 21, 2025
Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotypingAlison M Cheung, Dan Wang, Mary Anne Quintayo, et al.
NPJ Breast Cancer|March 2, 2026
Heterogeneity and immune microenvironment of early invasive estrogen receptor-positive breast cancer reveal an immune-rich subsetDrashti Jain, Linda Liao, Vida Talebian, et al.
Breast Cancer Research and Treatment|June 4, 2011
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancerMelanie Spears, Karen J Taylor, Alison F Munro, et al.
Oncotarget|September 16, 2015
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsMelanie Spears, Fouad Yousif, Nicola Lyttle, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|May 22, 2009
The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancerMelanie Spears, John Bartlett
Molecular Diagnosis & Therapy|November 21, 2009
Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selectionMelanie Spears, John M S Bartlett
Journal of the National Cancer Institute|January 10, 2014
Validated or not validated? That is the questionJohn M S Bartlett, Kathleen I Pritchard, Melanie Spears
Genome Medicine|June 30, 2017
ISOWN: accurate somatic mutation identification in the absence of normal tissue controlsIrina Kalatskaya, Quang M Trinh, Melanie Spears, et al.
Journal for Immunotherapy of Cancer|June 4, 2026
Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to "revive" immunotherapy as a treatment strategy?Isabella Kojundzic, Cody Zatzman, Julia Belone Lopes, et al.
Journal of Ovarian Research|April 6, 2018
Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancerTaryne Chong, Amila Sarac, Cindy Q Yao, et al.
Breast Cancer Research : BCR|May 21, 2025
Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotypingAlison M Cheung, Dan Wang, Mary Anne Quintayo, et al.
NPJ Breast Cancer|March 2, 2026
Heterogeneity and immune microenvironment of early invasive estrogen receptor-positive breast cancer reveal an immune-rich subsetDrashti Jain, Linda Liao, Vida Talebian, et al.
Breast Cancer Research and Treatment|June 4, 2011
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancerMelanie Spears, Karen J Taylor, Alison F Munro, et al.
Oncotarget|September 16, 2015
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsMelanie Spears, Fouad Yousif, Nicola Lyttle, et al.
Pageof 3